SERCA2 phosphorylation at serine 663 is a key regulator of Ca2+ homeostasis in heart diseases - Archive ouverte HAL
Article Dans Une Revue Nature Communications Année : 2023

SERCA2 phosphorylation at serine 663 is a key regulator of Ca2+ homeostasis in heart diseases

Résumé

Despite advances in cardioprotection, new therapeutic strategies capable of preventing ischemia-reperfusion injury of patients are still needed. Here, we discover that sarcoplasmic/endoplasmic reticulum Ca 2+ ATPase (SERCA2) phosphorylation at serine 663 is a clinical and pathophysiological event of cardiac function. Indeed, the phosphorylation level of SERCA2 at serine 663 is increased in ischemic hearts of patients and mouse. Analyses on different human cell lines indicate that preventing serine 663 phosphorylation significantly increases SERCA2 activity and protects against cell death, by counteracting cytosolic and mitochondrial Ca 2+ overload. By identifying the phosphorylation level of SERCA2 at serine 663 as an essential regulator of SERCA2 activity, Ca 2+ homeostasis and infarct size, these data contribute to a more comprehensive understanding of the excitation/contraction coupling of cardiomyocytes and establish the pathophysiological role and the therapeutic potential of SERCA2 modulation in acute myocardial infarction, based on the hotspot phosphorylation level of SERCA2 at serine 663 residue.
Fichier principal
Vignette du fichier
s41467-023-39027-x.pdf (3.08 Mo) Télécharger le fichier
Origine Publication financée par une institution

Dates et versions

hal-04316213 , version 1 (06-06-2024)

Identifiants

Citer

Fabrice Gonnot, Laura Boulogne, Camille Brun, Maya Dia, Yves Gouriou, et al.. SERCA2 phosphorylation at serine 663 is a key regulator of Ca2+ homeostasis in heart diseases. Nature Communications, 2023, 14 (1), pp.3346. ⟨10.1038/s41467-023-39027-x⟩. ⟨hal-04316213⟩
60 Consultations
22 Téléchargements

Altmetric

Partager

More